IL6 and rheumatoid arthritis: Since IL-17 not only mediates the synthesis of ICAM-1 and diverse cytokines (IL-6 and TNF-α, etc), but also accelerates collagen degradation via diminishing collagen and proteo glycan synthesis while enhancing bone erosion, its inhibition was believed to be an effective way to ameliorate RA.